March 19 (Reuters) - Intelgenx Technologies Corp IGX.V :
* INTELGENX ANNOUNCES PROPOSED ACQUISITION OF LABOVAL
* INTELGENX TECHNOLOGIES CORP - DEAL FOR TOTAL CASH
CONSIDERATION
OF UP TO CA$5 MILLION
* INTELGENX TECHNOLOGIES CORP - INTENDS TO FINANCE
ACQUISITION AND
RELATED FEES AND COSTS BY WAY OF PRIVATE PLACEMENT EQUITY
FINANCING
* INTELGENX TECHNOLOGIES CORP - CO'S OBLIGATION TO CLOSE
ACQUISITION IS CONDITIONAL UPON CO RAISING AT LEAST US$10
MILLION UNDER OFFERING
* INTELGENX - PROCEEDS RAISED IN ADDITION TO THOSE REQUIRED
FOR
DEAL WOULD BE USED TO FINANCE CO'S MONTELUKAST PHASE 2B CLINICAL
TRIAL, WORKING CAPITAL
Source text for Eikon: ID:nGNX6Db0DV
Further company coverage: IGX.V
((Reuters.Briefs@thomsonreuters.com;))